# Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease

> **NCT04391712** · PHASE2 · COMPLETED · sponsor: **Lowell General Hospital** · enrollment: 10 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DEVICE:** MLS Laser
- **OTHER:** Regular Inpatient Medical Care

## Key facts

- **NCT ID:** NCT04391712
- **Lead sponsor:** Lowell General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-30
- **Primary completion:** 2020-05-15
- **Final completion:** 2020-07-16
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04391712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04391712, "Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04391712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*